In this free webinar, learn about a one-step automated method for affinity-specific detection, quantification and isolation of extracellular vesicles for downstream analysis, which would lead to unbiased and reproducible development of extracellular vesicle-based biomarkers in disease and therapy research. Attendees will gain insights into the complexities of detecting, quantifying and isolating extracellular vesicles. The featured speakers will discuss a more efficient and unbiased approach to biomarker development. The speakers will also share insights into the applications of this advanced technology in development of early disease diagnosis, patient stratification and personalized treatment strategies.
TORONTO, Oct. 2, 2024 /PRNewswire-PRWeb/ -- In this webinar, the expert speakers will discuss a one-step automated method for affinity-specific detection, quantification and isolation of extracellular vesicles for downstream analysis, which would lead to unbiased and reproducible development of extracellular vesicle-based biomarkers in disease and therapy research.
Specific detection, quantification and isolation of extracellular vesicles is a particularly challenging task due to the heterogeneity of extracellular vesicles and the complexity of matrices in which they are typically found such as culture medium or blood plasma. The analytics for extracellular vesicles combined with liquid biopsy could lead to earlier diagnosis and stratified treatment that will save lives (e.g. cancer mortality reduction by 20-25 percent) and lower the healthcare burden cost (>5 percent reduction).
However, current methods to purify and quantify extracellular vesicles take a long time, introduce a bias and are costly and imprecise, thereby hampering progress in the research and development related to extracellular vesicles. However, the lack of methods to characterize the whole extracellular vesicle directly in crude samples restricts clinical sensitivity in diagnostics.
The expert speakers will be discussing a breakthrough label-free fiber-optic method in an automated platform for biomolecular sensing. This method combines affinity-based quantification with simultaneous affinity isolation or downstream analysis.
This integrated solution using a sensor dip-in probe is a new, selective, automated (scalable), fast (hours) and specific (purity up to 95%) method to accurately quantify and isolate extracellular vesicles directly from cell culture supernatant and plasma samples. Proof of concept data will be presented to demonstrate yield for downstream analysis and for specific capture of circulating neuronal tissue extracellular vesicles from human plasma.
Register for this webinar to learn how research studies and analysis workflows can become more efficient and effective from one-step immunospecific analytical isolation and collection of biologics, exosomes and extracellular vesicles or even of cells in suspension.
Join Dr. Aida Montserrat Pagès, PhD, Scientist, ; and Dr. Ryan Pink, PhD, Reader in Molecular Biology and Genomics, Oxford Brookes University; CEO, MetaGuideX, for the on Tuesday, October 22, 2024, at 10am EDT (4pm CEST/EU-Central).
For more information, or to register for this event, visit .
About FOx BIOSYSTEMS
FOx BIOSYSTEMS is a company with a mission to revolutionize the life sciences and biopharmaceutical research market with innovative real-time, label-free analysis products. FOx BIOSYSTEMS provides fluidics-free biomolecular analysis systems that can reliably measure molecule interactions, from proteins to vesicles, phage, VLP and whole cells, in unpurified samples including cell culture supernatant, lysate, plasma and blood. Our innovative fiber-optic biosensor combines the ease of use of dip-in reading with the power of real-time binding analysis.
Contact
Kris Ver Donck
Tel: +32 11 28 69 73
Email: [email protected]
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit
For information about hosting a webinar visit
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected],
SOURCE Xtalks
Share this article